APUA headquarters is located in Boston, MA on the campus of Tufts University Medical School. APUA's specialized staff provides field consultations and lend specialized expertise to guide policy makers, provider organizations, and other stakeholders seeking to improve antimicrobial supply, use, and management decisions. Our leadership includes recognized medical and scientific experts, including Nobel laureates and members of national academies of medicine and science. The APUA local chapters serve as reliable resources for collection and dissemination of information and advocacy for appropriate antimicrobial access and management in these reforms. APUA also contracts and consults on national and global projects with partners. To learn more about these project partners please click here.

Board of Directors

Stuart B. Levy, MD; Chairperson & President, Director, Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, MA

Thomas F. O’Brien, MD; Vice President, Director, Microbiology Laboratory Brigham & Women’s Hospital, Boston, MA

Arnold G. Reinhold, MBA, Treasurer, Information Technology Consultant, Cambridge, MA

Bonnie Marshall, MT, Secretary, Research Associate, Microbiology Department, Tufts University School of Medicine, Boston, MA

Robert Gaynes, MD, Professor, Department of Medicine, Emory University School of Medicine

Shahin Gharakhanian, MD, Cambridge InnovationCenter

Christina Larkin, Chief Commercial Officer, Spero Therapeutics

Margaret Riley, PhD, Professor, Department of Biology, University of Massachusetts at Amherst

Philip D. Walson, MD, Professor of Pediatrics, University of Cincinnati, and Director, Clinical Pharmacology & Clinical Trials Office, Children's Hospital Medical Center, Cincinnati, OH

David White, PhD, Associate Dean for Research and Associate Director of the Tennessee Agricultural Experiment Station, University of Tennessee Institute of Agriculture

Mary E. Wilson, M.D., Clinical Professor of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco; Adjunct Professor of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Scientific Advisory Board

APUA Consultant Panel and Scientific Advisory Board

APUA’s Scientific Advisory Board and roster of expert consultants are based in 54 countries - 25 in the developing world.  This panel includes recognized experts on antimicrobial development, use, and resistance, with sub-specialties in pharmaceutical management, pharmacoeconomics, microbiology, internal medicine, pediatrics, public health, epidemiology, veterinary medicine/animal health, pharmacology, infection control/quality improvement, surveillance, provider training, clinical guidelines development, policy analysis, consumer education, and program administration.  Many have field experience in developing countries and are fluent in Spanish, French, and many other languages.

Consultant Panel

Aníbal Sosa, M.D. Professor Emeritus, Medical Microbiology and Tropical Diseases, University of Zulia School of Medicine, Tufts School of Medicine. Former Director of APUA International Chapter Programs.

Mirella Zulueta, M.D., Ph.D. Former Director of APUA Translational Medicine.

Scientific Advisory Board

Jacques F. Acar, M.D., Professor Emeritus, Universite Pierre et Marie Curie, Paris, France

Fernando Baquero Mochales, M.D., Director,Servicio de Microbiologia, Hospital “Ramon y Cajal”, Madrid, Spain

Michael L. Bennish, M.D., Director, Africa Centre for Health and Population Studies in Mtubatuba, South Africa, and Professor, Departments of Medicine & Pediatrics, Tufts-New England Medical Center, Boston, Mass., USA

Otto Cars, M.D., Ph.D., Senior Professor of Infectious Diseses, Uppsala University, Sweden.

Patrice Courvalin, M.D., FRCP, Head of Antibacterial Agents Unit and of the (French) National Reference Center for Antibiotics, Institut Pasteur, Paris, France

Jose Ramiro Cruz, Ph.D., Regional Advisor (Guatemala) for Laboratory and Blood Services, Unit of Essential Medicines, Vaccines & Technologies; Pan American Health Organization; Washington DC

Julian Davies, Ph.D., Professor Emeritus, University of British Columbia, and Vice President and Chief Scientific Officer, TerraGen Diversity, Inc., Vancouver, BC, Canada

Abdoulaye Djimde, Associate Professor, Microbiology and Mycology, Chief of Molecular Epidemiology and Drug Resistance Unit, University of Science, Techniques and Technologies, Bamako, Mali

Stanley Falkow, Ph.D., Cahill Professor in Cancer Research, Emeritus, Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA

Paul Farmer, M.D., Co-founder, Partners In Health; Presley Professor of Social Medicine and Chair, Department of Global Health and Social Medicine, Harvard Medical School; and Chief, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Mass., USA

Walter Gilbert, Ph.D., Loeb University Professor, Department of Molecular & Cellular Biology, Harvard University, Cambridge, Mass., USA (1980 Nobel Prize in Chemistry)

Herman Goossens, Ph.D., Director, Department of Clinical Microbiology, University Hospital, Antwerp, Belgium, and Project Leader of ESAC-European Surveillance on Antimicrobial Consumption

Sherwood L. Gorbach, M.D., Professor, Community Health & Medicine, Tufts University School of Medicine, Boston, Mass., USA

Ian M. Gould, Ph.D., Consultant Microbiologist, Aberdeen Royal Hospital, Aberdeen, Scotland

David Heymann, M.D., Chair of the Health Protection Agency in London, Head of the Centre on Global Health Security at Chatham House and Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine

George Jacoby, M.D., Infectious Disease Section, Lahey Clinic, Burlington, Mass., USA and Associate Professor of Medicine, Harvard Medical School

Sam Kariuki, Ph.D., Chief Research Scientist and Director, Centre for Microbiology Research at KEMRI in Nairobi; Wellcome Trust Sanger Institute International Fellow

Ellen L. Koenig, M.D., Principal Investigator, Institutto Dominicao De Estudios Virologicos (IDEV)

Calvin M. Kunin, M.D., FACP, Clinical Professor, Department of Infectious Disease Section, University of Arizona

Jacobo Kupersztoch, Ph.D., Executive Director, Centro Communitario Mexicano, Dallas, Texas, USA

Stephen A. Lerner, M.D., Professor of Medicine, Division of Infectious Diseases, and Associate Dean, Wayne State University School of Medicine, Detroit, Michigan, USA

Jay A. Levy, M.D., Director, Laboratory for Tumor and AIDS Virus Research, and Professor, University of California, San Francisco, California, USA

Scott McEwen, D.V.M., D.V.Sc., ACVP, Professor, Department of Population Medicine, Ontario Veterinary College of the University of Guelph, Ontario, Canada

Jos. W.M. van der Meer, M.D., FRCP, Professor of Internal Medicine and Chairman of the Division of General Internal Medicine, University Medical Center of Nijmegen, The Netherlands

Richard P. Novick, M.D., Professor of Microbiology and Medicine, New York University Medical Center, New York, NY, USA

Iruka Okeke, Ph.D., Assistant Professor of Biology, Haverford College, Haverford, Pennsylvania, USA & Nigeria

Maria Eugenia Pinto, M.D., Faculty of Medicine/Microbiology, University of Chile, Santiago, Chile

Vidal Rodriguez-Lemoine, M.D., Director, Centro Venezolano de Colecciones de Microorganismos, Universidad Central de Venezuela, Caracas, Venezuela

José Ignacio Santos, M.D., Director, National Immunization Council, Colonia Merced Gomez D.F., Mexico, and Professor of Experimental Medicine and Infectious Diseases at the School of Medicine, UNAM

Mervyn Shapiro, Ph.D., ChB., Director, Department of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel

K.B. Sharma, Ph.D., Director, Centre for Infectious Disease Education & Research, New Delhi, India

Atef M. Shibil, Ph.D., Professor of Microbiology, King Saud University College of Pharmacy, Riyadh, Saudi Arabia

E. John Threlfall, Ph.D., Head, Antibiotic Resistance/Molecular Epidemiology Unit, Laboratory of Enteric Pathogens, Health Protection Agency, London, England

Alexander Tomasz, M.D., Microbiology Laboratory, Rockefeller University, New York, New York, USA

Thelma E. Tupasi, M.D., Head, Infectious Disease Section, Makati Medical Center, Manila, The Philippines

Anne K. Vidaver, Ph.D., Professor Emerita, Department of Plant Pathology, University of Nebraska, Lincoln, Nebraska, USA

Fu Wang, M.D., Professor, Honorary Director, Institute of Antibiotics, Huashan Hospital, Fudan University

Thomas Wellems, M.D., Ph.D., Acting Co-chief, Laboratory of Parasitic Diseases, and Laboratory of Malaria and Vector Research, National Institutes of Health/ National Institute of Allergy & Infectious Diseases, Bethesda, Maryland, USA

Bernd Wiedemann, M.D., Professor, Pharmazeutisch Microbiolgie, University at Bonn, Germany.